Neuromodulation of Inflammation and Endothelial Function — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neuromodulation of Inflammation and Endothelial Function — Stella

Home/Systolic Heart Failure/

View on ClinicalTrials.gov

Recruiting

Back to Systolic Heart Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Key details

Sponsor

University of Oklahoma

Collaborators

National Institute on Aging (NIA)

Enrollment target

~158 participants

Started

September 2022

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 85 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.